Literature DB >> 11533170

Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.

R García-Navarro1, B Blanco-Urgoiti, P Berraondo, R Sánchez de la Rosa, A Vales, S Hervás-Stubbs, J J Lasarte, F Borrás, J Ruiz, J Prieto.   

Abstract

Woodchuck hepatitis virus (WHV) and hepatitis B virus (HBV) are closely similar with respect to genomic organization, host antiviral responses, and pathobiology of the infection. T-cell immunity against viral nucleocapsid (HBcAg or WHcAg) has been shown to play a critical role in viral clearance and protection against infection. Here we show that vaccination of healthy woodchucks by gene gun bombardment with a plasmid coding for WHcAg (pCw) stimulates proliferation of WHcAg-specific T cells but that these cells do not produce significant levels of gamma interferon (IFN-gamma) upon antigen stimulation. In addition, animals vaccinated with pCw alone were not protected against WHV inoculation. In order to induce a Th1 cytokine response, another group of woodchucks was immunized with pCw together with another plasmid coding for woodchuck interleukin-12 (IL-12). These animals exhibited WHcAg-specific T-cell proliferation with high IFN-gamma production and were protected against challenge with WHV, showing no viremia or low-level transient viremia after WHV inoculation. In conclusion, gene gun immunization with WHV core generates a non-Th1 type of response which does not protect against experimental infection. However, steering the immune response to a Th1 cytokine profile by IL-12 coadministration achieves protective immunity. These data demonstrate a crucial role of Th1 responses in the control of hepadnavirus replication and suggest new approaches to inducing protection against HBV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533170      PMCID: PMC114475          DOI: 10.1128/JVI.75.19.9068-9076.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Current topics in hepatitis B.

Authors:  J N Zuckerman; A J Zuckerman
Journal:  J Infect       Date:  2000-09       Impact factor: 6.072

2.  Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.

Authors:  J J Lasarte; F J Corrales; N Casares; A López-Díaz de Cerio; C Qian; X Xie; F Borrás-Cuesta; J Prieto
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection.

Authors:  P J Cote; B E Korba; R H Miller; J R Jacob; B H Baldwin; W E Hornbuckle; R H Purcell; B C Tennant; J L Gerin
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

4.  Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.

Authors:  A Tanghe; O Denis; B Lambrecht; V Motte; T van den Berg; K Huygen
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence.

Authors:  F Galibert; T N Chen; E Mandart
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

6.  Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits.

Authors:  J L Gerin; R M Faust; P V Holland
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

7.  Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus.

Authors:  M A Feitelson; P L Marion; W S Robinson
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

8.  Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen.

Authors:  J L Dienstag; C E Stevens; A K Bhan; W Szmuness
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

Review 9.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

10.  Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.

Authors:  S Iwarson; E Tabor; H C Thomas; P Snoy; R J Gerety
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

View more
  11 in total

Review 1.  Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.

Authors:  V Schmitz; C Qian; J Ruiz; B Sangro; I Melero; G Mazzolini; I Narvaiza; J Prieto
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 2.  The promise of gene therapy in gastrointestinal and liver diseases.

Authors:  J Prieto; M Herraiz; B Sangro; C Qian; G Mazzolini; I Melero; J Ruiz
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

3.  Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes.

Authors:  Severin Gudima; Yiping He; Anja Meier; Jinhong Chang; Rongji Chen; Michal Jarnik; Emmanuelle Nicolas; Volker Bruss; John Taylor
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 4.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.

Authors:  Teresa M Wozniak; Anthony A Ryan; James A Triccas; Warwick J Britton
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 6.  The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

Authors:  Michael Roggendorf; Anna D Kosinska; Jia Liu; Mengji Lu
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-28       Impact factor: 6.915

7.  Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.

Authors:  Katherine H Liu; Mary A Ascenzi; Christine A Bellezza; Abraham J Bezuidenhout; Paul J Cote; Gloria Gonzalez-Aseguinolaza; Drew Hannaman; Alain Luxembourg; Claire F Evans; Bud C Tennant; Stephan Menne
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

8.  Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.

Authors:  Mengji Lu; Masanori Isogawa; Yang Xu; Gero Hilken
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

9.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

Authors:  Robyn Puro; Robert J Schneider
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.